Why This Pharmaceutical Stock Jumped Almost 100% This Week
A mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
Understand why methodology matters in investing and how it affects risk assessment, accuracy, and investment outcomes.
21,903 articlesA mid-cap biotech surged close to 100% on news of a major deal and regulatory progress. This guide breaks down what h...
On July 22, AI-driven hardware names moved the dial as SMCI posted a surprising margin beat and a burst of orders. Th...
Retirees are discovering a niche income strategy that delivers roughly 5% yields with minimal price swings. This arti...
February brought a notable rotation in markets. Developed markets ex-US, gold, and REITs stood out as some of the top...
Investors often react to headlines about Coinbase and Circle with a knee-jerk fear or optimism. This piece explains w...
A clash between the fast-food giant’s value-menu push and a traffic-led steakhouse model drives a new look at restaur...
Investors are watching GameSquare closely as 2025 earnings unfold. This guide explains what to look for in the Q4 res...
When a high-level insider trims a stake, it can spark questions about a company’s near-term prospects. This article b...
Tech giants are investing heavily in AI, yet leaders warn that compute costs may outstrip wages. New MIT findings and...
A single quarterly beat isn’t the whole story. Micron’s latest results point to a multi-decade growth thesis that goe...
Palantir's CEO used a televised interview to question AI pricing models, highlighting data ownership and sovereignty ...
Rivian has faced volatility, with a notable pullback this year. This guide breaks down what’s driving the moves, what...